Twist Bioscience Corporation — Income Charts
2 years of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$377M
Cost of Revenue
$186M
R&D
$80M
SG&A
$247M
D&A
$25M
Operating Income
$-136M
EBITDA
$-111M
Interest Expense
$29K
Interest Income
$0
Other Income/Expense
$59M
Pretax Income
$-77M
Tax Provision
$719K
Net Income
$-78M
Operating Margin
-36.2%
Net Margin
-20.6%
Effective Tax Rate
-0.9%
Deferred Tax Assets
$15M
Deferred Tax Liabilities
$0
DTA Valuation Allowance
$383M
Tax Credit Carryforwards
$68M
NOL Carryforwards
$232M
ETR (Continuing Operations)
-1.0%
ETR Federal Statutory
21.0%
Operating Lease Cost
$15M
Revenue YoY Variation
20.3%
Income YoY Variation
38.3%